Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Alzheimer Disease and Associated Disorders|March 15, 2011
Psychotropic drug effects on gene transcriptomics relevant to Alzheimer diseaseEdward C LauterbachAmerican Journal of Neurodegenerative Disease|April 14, 2016
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseEdward C LauterbachProgress in Neuro-Psychopharmacology & Biological Psychiatry|April 18, 2012
Psychotropic drug effects on gene transcriptomics relevant to Parkinson's diseaseEdward C LauterbachPsychopharmacology Bulletin|October 15, 2016
Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging MoleculeEdward C LauterbachProgress in Neuro-Psychopharmacology & Biological Psychiatry|October 11, 2012
Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription--potential to delay Parkinson's diseaseEdward C LauterbachThe Psychiatric Clinics of North America|November 20, 2004
The neuropsychiatry of Parkinson's disease and related disordersEdward C LauterbachMedical Hypotheses|March 4, 2011
Dextromethorphan as a potential rapid-acting antidepressantEdward C LauterbachMedical Hypotheses|March 10, 2012
An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphanEdward C LauterbachInternational Journal of Molecular Sciences|November 20, 2013
Neuroprotective effects of psychotropic drugs in Huntington's diseaseEdward C LauterbachNeural Regeneration Research|January 27, 2017
Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modificationEdward C LauterbachPageof 4